The spectrum of primary immunodeficiency disorders in Australia

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 3, 1997, Pages 415-423

  Baumgart, Karl W ^a   Britton, Warwick J ^a   Kemp, Andrew ^b   French, Martyn ^c   Roberton, Don ^d  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Australia; Gammaglobulin; Immunodeficiency; Primary; Register

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; AUSTRALIA; CHRONIC GRANULOMATOUS DISEASE; COMBINED IMMUNODEFICIENCY; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE DEFICIENCY; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

EID: 0030764946     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70257-4     Document Type: Article

References (28)

1. Cooper MD, Butler JL. Primary immunodeficiency diseases. In: Paul WE, editor. Fundamental immunology. 3rd ed. New York: Raven Press; 1994. p. 1034-9.
2. Stiehm ER. Immunodeficiency disorders: general considerations. In: Stiehm ER, editor. Immunologic disorders in infants and children. 3rd ed. Philadelphia: WB Saunders; 1989. p. 157-95.
3. Primary immunodeficiency diseases - report of a WHO scientific group. Clin Exp Immunol 1995;99(suppl 1):1-24.
4. Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Liebermann P. Incidence of cancer in 98 patients with common variable immunodeficiency. J Clin Immunol 1987;7:294-302.
5. Baumgart KW, Cook MC. Therapeutic applications of intravenous immunoglobulin. Australian Journal of Hospital Pharmacy 1992;23:148-51.
6. Vetrie D, Vorechovsky I, Sideras P, et al. The gene involved in X-linked agammaglobulinaemia is a member of the Scr family of protein-tyrosine kinases. Nature 1993;361:226-3.
7. Leonard WJ. The defective gene in X-linked severe combined immunodeficiency encodes a shared interleukin receptor subunit: implications for cytokine pleiotropy and redundancy. Curr Opin Immunol 1994;6:631-5.
8. Laman JD, Claasen E, Noelle RJ. Immunodeficiency due to a faulty interaction between T cells and B cells. Curr Opin Immunol 1994;6:636-41.
9. Luzi G, Pesce AM, Rinaldi S. Primary immunodeficiencies in Italy. Data revised from the Italian Register of Immunodeficiencies-IRID (1977-1988). Immunology Clinics 1989;8:45-53.
10. Hayakawa H, Iwata T, Yata J, Kobayashi N. Primary immunodeficiency syndrome in Japan. I. Overview of a nationwide survey on primary immunodeficiency syndrome. J Clin Immunol 1981;1:31-9.
11. Spector BD, Perry GS III, Kersey JH. Genetically determined immunodeficiency disease (GDID) and malignancy: report from Immunodeficiency-Cancer Registry. Clin Immunol Immunopathol 1978;11:12-29.
12. Rosen FS, Wedgewood RJ, Eibl M. Primary immunodeficiency disorders. Report of a WHO scientific group. Clin Immunol Immunopathol 1986;40:166-80.
13. McNulty AM, Kaldor JM, McDonald AM, Baumgart K, Cooper DA. Acquired immunodeficiency without evidence of HIV infection: a national retrospective survey. BMJ 1994;308:825-6.
14. Hosking CS, Roberton DM. Epidemiology and treatment of hypogammaglobulinaemia. Birth Defects: Original Article Series 1983;19:223-7.
15. Walker AM, Kemp AS. Hill DJ, Shetton MJ. Features of transient hypogammaglobinaemia in infants screened for immunological abnormalities. Arch Dis Child 1994;70:183-6.
16. Jefferis R, Kumararative DS. Selective IgG subclass deficiencies: quantification and clinical relevance. Clin Exp Immunol 1990;81:357-67.
17. Chapel HM. Consensus on diagnosis and management of primary antibody deficiencies. Br J Med 1995;308:581-5.
18. Keller T, McGrath K, Newland A, Gatenby P, Cobcroft R, Gibson J. Indications for use of intravenous immunoglobulin. Med J Aust 1993;159:204-6.
19. Fasth A. Primary immunodeficiency disorders in Sweden: cases among children 1974-1979. J Clin Immunol 1982;2:86-92.
20. Griscelli C, Lisowska-Grospierre B, Mach B. Combined immunodeficiency with defective expression in MHC class II genes. In: Rosen FS, Seligman M, editors. Immunodeficiencies. Chur: Harwood Academic; 1993. p. 141-54.
21. Waldmann TA, Nelson DL. Inherited immunodeficiency. In: Frank MM, Austen KF, Claman HN, Unanue ER, editors. Immunologic diseases. 5th ed. Boston: Little Brown: 1995. p. 287-429.
22. Derry JMJ, Ohs HD, Francke U. Isolation of a novel gene mutated in Wiskott Aldrich syndrome. Cell 1994;78:635-44.
23. Savitsky K, Bar-Shina A, Gilad S, Rotman G, Ziv Y, Vanagaite L, et al. A single ataxia-teiangiectasia gene with a product similar to PI-3 kinase. Science 1995;268:1749-53.
24. Woods CG, Taylor AMR. Ataxia telangiectasia in the British Isles: the clinical and laboratory features of 70 affected individuals. QJM 1992;82:169-79.
25. Dinauer M, Orkin S. Chronic granulomatous disease. Annu Rev Med 1992;3:117-24.
26. Sullivan JL, Woden BA. X-linked lymphoproliferative syndrome. Immunodef Rev 1992;1:325-38.
27. Dwyer JM. Manipulating the immune system with immunoglobulin. N Engl J Med 1992;326:107-37.
28. Cunningham-Rundles C, Kazbay K, Hassett J, Zhou Z, Mayer L. Enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol-conjugated interleukin-2. N Engl J Med 1994;331:918-21.